1
[ Assays and diagnostic screening kits composed primarily of reagents for scientific analysis and research for diagnosis of disorders and physiological processes and for measurement of disease markers for scientific purposes ]
5
Pharmaceutical preparations for use in enzyme therapy; pharmaceutical preparations for use in treatment of genetic disorders; [ pharmaceutical preparations for use in burn and wound debridement or cleaning; pharmaceuticals for treatment of inflammation, infectious diseases and cardiovascular diseases; ] assays and diagnostic screening kits composed primarily of reagents for clinical and medical use for analysis and diagnosis of disorders and physiological processes and for measurement of disease markers for medical purposes; carbohydrate inhibiting enzymes for use in disease treatment; [ fungal lytic enzymes for the treatment of fungal infections; ] pharmaceuticals for treatment of lysosomal storage diseases; pharmaceuticals for treatment of mucopolysaccharidoses; pharmaceuticals for treatment of carbohydrate-inhibiting enzyme disorders; [ proteins and enzymes for the production, purification and isolation of biologics for use in the treatment of medical conditions; ] biologics produced by recombinant DNA technology for use in the treatment of pathological medical conditions